These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33691433)

  • 1. Survival differences between chemotherapy and chemoradiotherapy in metastatic esophageal cancer: a propensity score-matched study based on the SEER database.
    Shao Y; Zhang M; Ye L; Chen D; Wu QC; Zhang C
    Ann Palliat Med; 2021 Apr; 10(4):3826-3835. PubMed ID: 33691433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis.
    Wang Q; Lang J; Li T; Peng L; Dai W; Jiang Y; Xie T; Fang Q; Wang Y; Wu L; Cao B; Han Y
    Radiat Oncol; 2020 May; 15(1):119. PubMed ID: 32448253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between radical surgery and chemoradiotherapy in patients with cervical esophageal cancer: a propensity score matched analysis.
    Qi K; Lin G; Liu H; Zhang X; Chen Z; Li J
    BMC Surg; 2023 May; 23(1):119. PubMed ID: 37170089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
    Pan L; Zhang Y; Gao Y; Qiu J
    Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A).
    Chen M; Liu X; Han C; Wang X; Zhao Y; Pang Q; Sun X; Li G; Zhang K; Li L; Qiao X; Lin Y; Chen J; Xiao Z
    BMC Cancer; 2020 Jan; 20(1):36. PubMed ID: 31941487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses.
    Shi Z; Zhu X; Ke S; Qiu H; Cai G; Zhangcai Y; Chen Y
    Radiother Oncol; 2021 Nov; 164():236-244. PubMed ID: 34627936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database.
    Xie L; Zhang Z
    Front Immunol; 2024; 15():1334992. PubMed ID: 38292873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort.
    Zhang R; Zou J; Li P; Li Q; Qiao Y; Han J; Huang K; Ruan P; Lin H; Song Q; Fu Z
    Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31175353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiotherapy Is Superior to Radiotherapy Alone in Esophageal Cancer Patients Older Than 65 Years: A Propensity Score-Matched Analysis of the SEER Database.
    Xia X; Gao Q; Ge X; Liu Z; Di X; Sun X; Yang Y
    Front Oncol; 2021; 11():736448. PubMed ID: 34557416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
    Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
    Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and toxicities of locally advanced esophageal squamous cell carcinoma patients treated with early thoracic radiation therapy after induction chemotherapy.
    Qiu J; Lin H; Yu Y; Ke D; Li H; Zheng H; Zheng Q; Wang Z; Lin M; Yang J; Liu L; Zhang M; Liu T; Wu Y; Li J; Lai J
    Int J Clin Oncol; 2023 Apr; 28(4):550-564. PubMed ID: 36735115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
    Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
    Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effectiveness of Chemoradiotherapy in Elderly Patients with Pancreatic Cancer: A Population-Based Study Based on the SEER Database.
    Nie D; Liu S; Cai S; Xing X; Xu F
    Adv Ther; 2022 Nov; 39(11):5043-5057. PubMed ID: 36044179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
    Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiotherapy vs radiotherapy for non-surgical locally advanced laryngeal squamous cell carcinoma patients: a propensity score-matched study and practical nomogram construction.
    Zhang Y; Wang Z; Zheng Y
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1449-1456. PubMed ID: 38158418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis.
    Li J; Jia Y; Cheng Y; Wang J
    Cancer Med; 2020 Jul; 9(14):5025-5034. PubMed ID: 32441890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis.
    Qi WX; Chen C; Zhao S; Chen J
    Int J Clin Oncol; 2022 Feb; 27(2):340-347. PubMed ID: 34731352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database.
    Zhu Y; Liu X; Lin Y; Tang L; Yi X; Xu H; Yuan Y; Chen Y
    Eur J Med Res; 2023 Sep; 28(1):310. PubMed ID: 37658421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy improves the survival of patients with metastatic esophageal squamous cell carcinoma: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database.
    Zhang R; Jia M; Li P; Han J; Huang K; Li Q; Qiao Y; Xu T; Ruan P; Hu Q; Fan G; Song Q; Fu Z
    Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 30277502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.
    Barbetta A; Hsu M; Tan KS; Stefanova D; Herman K; Adusumilli PS; Bains MS; Bott MJ; Isbell JM; Janjigian YY; Ku GY; Park BJ; Wu AJ; Jones DR; Molena D
    J Thorac Cardiovasc Surg; 2018 Jun; 155(6):2710-2721.e3. PubMed ID: 29548582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.